Literature DB >> 14742251

Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction.

Kyosuke Takeshita1, Mutsuharu Hayashi, Shigeo Iino, Takahisa Kondo, Yasuya Inden, Mitsunori Iwase, Tetsuhito Kojima, Makoto Hirai, Masafumi Ito, David J Loskutoff, Hidehiko Saito, Toyoaki Murohara, Koji Yamamoto.   

Abstract

Plasminogen activator inhibitor-1 (PAI-1) plays a critical role in tissue fibrosis by inactivating matrix metalloproteinases, which might effect on the progression of left ventricular dysfunction. However, little has been known about the expression of PAI-1 during cardiac remodeling. We used a mouse model of myocardial infarction (MI) by coronary ligation, in which the progression of left ventricular remodeling was confirmed by echocardiography. Histological examination showed that interstitial and perivascular fibrosis progressed in the post-MI (PMI) heart at 4 weeks after the procedure. We observed the dramatic induction of cardiac PAI-1 mRNA and PAI-1 antigen in plasma in the PMI mice, as compared with the sham-operated (sham) mice. In situ hybridization analysis demonstrated that strong signals for PAI-1 mRNA were localized to cardiomyocytes in the border of infarct area and around fibrous lesions, and to perivascular mononuclear cells, which seemed to be mast cells, only in hearts of the PMI mice. Importantly, less development of cardiac fibrosis after MI was observed in mice deficient in PAI-1 as compared to wild-type mice. The mRNA expression of cytokines, transforming growth factor-beta, and tumor necrosis factor-alpha, was also increased in hearts of the PMI mice, but not in the sham mice. These observations suggest that cardiomyocytes and mast cells contribute to the increased PAI-1 expression, resulting in the development of interstitial and perivascular fibrosis in the PMI heart, and that the regional induction of cytokines may be involved in this process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14742251      PMCID: PMC1602257          DOI: 10.1016/S0002-9440(10)63135-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  Alteration of transforming growth factor-beta1 response involves down-regulation of Smad3 signaling in myofibroblasts from skin fibrosis.

Authors:  P Reisdorf; D A Lawrence; V Sivan; E Klising; M T Martin
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.

Authors:  N Hattori; J L Degen; T H Sisson; H Liu; B B Moore; R G Pandrangi; R H Simon; A F Drew
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

3.  Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction.

Authors:  E Creemers; J Cleutjens; J Smits; S Heymans; L Moons; D Collen; M Daemen; P Carmeliet
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

4.  Cardiac functional and structural alterations induced by endotoxin in rats: importance of platelet-activating factor.

Authors:  M Iwase; M Yokota; K Kitaichi; L Wang; K Takagi; T Nagasaka; H Izawa; T Hasegawa
Journal:  Crit Care Med       Date:  2001-03       Impact factor: 7.598

5.  Expression of transforming growth factor-beta and tumor necrosis factor-alpha in the plasma and tissues of mice with lupus nephritis.

Authors:  K Yamamoto; D J Loskutoff
Journal:  Lab Invest       Date:  2000-10       Impact factor: 5.662

6.  Angiotensin-converting enzyme inhibition attenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese diabetic mice.

Authors:  A K Zaman; S Fujii; H Sawa; D Goto; N Ishimori; K Watano; T Kaneko; T Furumoto; T Sugawara; I Sakuma; A Kitabatake; B E Sobel
Journal:  Circulation       Date:  2001-06-26       Impact factor: 29.690

7.  Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase.

Authors:  K A Lindstedt; Y Wang; N Shiota; J Saarinen; M Hyytiäinen; J O Kokkonen; J Keski-Oja; P T Kovanen
Journal:  FASEB J       Date:  2001-06       Impact factor: 5.191

8.  Disruption of the myocardial extracellular matrix leads to cardiac dysfunction.

Authors:  H E Kim; S S Dalal; E Young; M J Legato; M L Weisfeldt; J D'Armiento
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

9.  Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation.

Authors:  P Carmeliet; L Moons; R Lijnen; M Baes; V Lemaître; P Tipping; A Drew; Y Eeckhout; S Shapiro; F Lupu; D Collen
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

10.  Complete antithrombin deficiency in mice results in embryonic lethality.

Authors:  K Ishiguro; T Kojima; K Kadomatsu; Y Nakayama; A Takagi; M Suzuki; N Takeda; M Ito; K Yamamoto; T Matsushita; K Kusugami; T Muramatsu; H Saito
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

View more
  45 in total

1.  Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor.

Authors:  Anne Masset; Catherine Maillard; Nor Eddine Sounni; Nathalie Jacobs; Françoise Bruyére; Philippe Delvenne; Marlene Tacke; Thomas Reinheckel; Jean-Michel Foidart; Lisa M Coussens; Agnès Noël
Journal:  Int J Cancer       Date:  2010-03-15       Impact factor: 7.396

2.  Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts.

Authors:  Jianyong Zhong; Hai-Chun Yang; Valentina Kon; Agnes B Fogo; Daniel A Lawrence; Ji Ma
Journal:  Lab Invest       Date:  2014-03-31       Impact factor: 5.662

Review 3.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

4.  Uridine triphosphate (UTP) induces profibrotic responses in cardiac fibroblasts by activation of P2Y2 receptors.

Authors:  Oscar O Braun; David Lu; Nakon Aroonsakool; Paul A Insel
Journal:  J Mol Cell Cardiol       Date:  2010-05-13       Impact factor: 5.000

Review 5.  Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.

Authors:  Matteo Cesari; Marco Pahor; Raffaele Antonelli Incalzi
Journal:  Cardiovasc Ther       Date:  2010-07-07       Impact factor: 3.023

6.  Hydrolysis of extracellular ATP by ectonucleoside triphosphate diphosphohydrolase (ENTPD) establishes the set point for fibrotic activity of cardiac fibroblasts.

Authors:  David Lu; Paul A Insel
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

7.  Deleterious effects of lack of cardiac PAI-1 after coronary occlusion in mice and their pathophysiologic determinants.

Authors:  A K M Tarikuz Zaman; Satoshi Fujii; David J Schneider; Douglas J Taatjes; H Roger Lijnen; Burton E Sobel
Journal:  Histochem Cell Biol       Date:  2007-06-19       Impact factor: 4.304

8.  Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture.

Authors:  Zhi Xu; Francis J Castellino; Victoria A Ploplis
Journal:  Blood       Date:  2009-12-15       Impact factor: 22.113

9.  Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction.

Authors:  Yu-Yu Yao; Hang Yin; Bo Shen; Lee Chao; Julie Chao
Journal:  J Card Fail       Date:  2007-09       Impact factor: 5.712

10.  Validation of the vitronectin knockout mouse as a model for studying myocardial infarction: Vitronectin appears to influence left ventricular remodelling following myocardial infarction.

Authors:  Gordon E Pate; Hubert P Walinski; Lubos Bohunek; Thomas J Podor
Journal:  Exp Clin Cardiol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.